274 related articles for article (PubMed ID: 8538347)
1. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene.
Stewart PM; Krozowski ZS; Gupta A; Milford DV; Howie AJ; Sheppard MC; Whorwood CB
Lancet; 1996 Jan; 347(8994):88-91. PubMed ID: 8538347
[TBL] [Abstract][Full Text] [Related]
2. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
Whorwood CB; Stewart PM
J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
[TBL] [Abstract][Full Text] [Related]
3. Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state.
Li A; Li KX; Marui S; Krozowski ZS; Batista MC; Whorwood CB; Arnhold IJ; Shackleton CH; Mendonca BB; Stewart PM
J Hypertens; 1997 Dec; 15(12 Pt 1):1397-402. PubMed ID: 9431844
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.
Li A; Tedde R; Krozowski ZS; Pala A; Li KX; Shackleton CH; Mantero F; Palermo M; Stewart PM
Am J Hum Genet; 1998 Aug; 63(2):370-9. PubMed ID: 9683587
[TBL] [Abstract][Full Text] [Related]
5. A new compound heterozygous mutation in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.
Kitanaka S; Katsumata N; Tanae A; Hibi I; Takeyama K; Fuse H; Kato S; Tanaka T
J Clin Endocrinol Metab; 1997 Dec; 82(12):4054-8. PubMed ID: 9398712
[TBL] [Abstract][Full Text] [Related]
6. 11 beta-Hydroxysteroid dehydrogenases: key enzymes in determining tissue-specific glucocorticoid effects.
Edwards CR; Benediktsson R; Lindsay RS; Seckl JR
Steroids; 1996 Apr; 61(4):263-9. PubMed ID: 8733012
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
[TBL] [Abstract][Full Text] [Related]
8. A genetic defect resulting in mild low-renin hypertension.
Wilson RC; Dave-Sharma S; Wei JQ; Obeyesekere VR; Li K; Ferrari P; Krozowski ZS; Shackleton CH; Bradlow L; Wiens T; New MI
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10200-5. PubMed ID: 9707624
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the 11 beta-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth.
Krozowski ZS; Stewart PM; Obeyesekere VR; Li K; Ferrari P
Clin Exp Hypertens; 1997; 19(5-6):519-29. PubMed ID: 9247735
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720
[TBL] [Abstract][Full Text] [Related]
11. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC
Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
[TBL] [Abstract][Full Text] [Related]
13. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
Ferrari P; Lovati E; Frey FJ
J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
[TBL] [Abstract][Full Text] [Related]
14. 11beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension.
Hatakeyama H; Inaba S; Miyamori I
Hypertension; 1999 May; 33(5):1179-84. PubMed ID: 10334808
[TBL] [Abstract][Full Text] [Related]
15. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK
Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
[TBL] [Abstract][Full Text] [Related]
16. Two homozygous mutations in the 11 beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess.
Carvajal CA; Gonzalez AA; Romero DG; González A; Mosso LM; Lagos ET; Hevia Mdel P; Rosati MP; Perez-Acle TO; Gomez-Sanchez CE; Montero JA; Fardella CE
J Clin Endocrinol Metab; 2003 Jun; 88(6):2501-7. PubMed ID: 12788846
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess.
Wilson RC; Krozowski ZS; Li K; Obeyesekere VR; Razzaghy-Azar M; Harbison MD; Wei JQ; Shackleton CH; Funder JW; New MI
J Clin Endocrinol Metab; 1995 Jul; 80(7):2263-6. PubMed ID: 7608290
[TBL] [Abstract][Full Text] [Related]
18. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform.
Stewart PM; Murry BA; Mason JI
J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966
[TBL] [Abstract][Full Text] [Related]
19. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.
Mune T; Rogerson FM; Nikkilä H; Agarwal AK; White PC
Nat Genet; 1995 Aug; 10(4):394-9. PubMed ID: 7670488
[TBL] [Abstract][Full Text] [Related]
20. Type 2 11 beta-hydroxysteroid dehydrogenase in foetal and adult life.
Stewart PM; Whorwood CB; Mason JI
J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):465-71. PubMed ID: 8547171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
